Preventing recurrence of focal segmental glomerulosclerosis following renal transplantation: A case report

Pediatric Transplantation

Volumn 10, Issue 8, 2006, Pages 962-965

  Couloures, Kevin ^a   Pepkowitz, Samuel H ^a   Goldfinger, Dennis ^a   Kamil, Elaine S ^a   Puliyanda, Dechu P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

FSGS; Plasmapheresis; Recurrence

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; FOCAL GLOMERULOSCLEROSIS; GRAFT REJECTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PROTEINURIA; RECURRENT DISEASE; RETRANSPLANTATION; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; CYCLOSPORINE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PLASMAPHERESIS; RECURRENCE;

EID: 33750584453     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00571.x     Document Type: Article

References (24)

1. STEPHANIAN E, MATAS AJ, MAUER SM, et al. Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis. Transplantation 1992; 53: 755-757.
2. DALL'AMICO R, GHIGGERI G, CARRARO M, et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 1999; 34: 1048-1055.
3. FIRST MR. Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis. Pediatr Nephrol 1995: 9(Suppl.): S40-S42.
4. BAUM MA, STABLEIN DM, PANZARINO VM, et al. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001; 59: 328-333.
5. DANTAL J, BAATARD R, HOURMANT M, et al. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 1991; 52: 827-831.
6. INGULLI E, TEJANI A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children - A single-center experience. Transplantation 1991; 51: 401-405.
7. SAVIN VJ, SHARMA R, SHARMA M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878-883.
8. WEBER S, GRIBOUVAL O, ESQUIVEL EL, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004; 66: 571-579.
9. VINCENTI F, GHIGGERI GM, New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 2005; 5: 1179-1185.
10. ARTERO ML, SHARMA R, SAVIN VJ, et al. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23: 574-581.
11. ANDRESDOTTIR MB, AJUBI N, CROOCKEWIT S, et al. Recurrent focal glomerulosclerosis: Natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999; 14: 2650-2656.
12. OHTA T, KAWAGUCHI H, HATTORI M, et al. Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001; 71: 628-633.
13. RIANTHAVORN P, BHAKTA N, GJERTSON DW, ETTENGER RB, A coherent approach to recurrent focal segmental glomerulosclerosis in children? The effects of high dose cyclosporine and pretransplant plasmapheresis. Pediatr Transplantation 2005; 9: 48.
14. COCHAT P, KASSIR A, COLON S, et al. Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 1993; 7: 50-54.
15. SALOMON R, GAGNADOUX MF, NIAUDET P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003; 75: 810-814.
16. RAAFAT RH, KALIA A, TRAVIS LB, et al. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 2004; 44: 50-56.
17. WU J, JAAR BG, BRIGGS WA, et al. High-dose mycophenolate mofetil in the treatment of posttransplant glomerular disease in the allograft: A case series. Nephron Clin Pract 2004; 98: c61-c66.
18. VAN BRUGGEN MC, WALGREEN B, RIJKE TP, et al. Attenuation of murine lupus nephritis by mycophenolate mofetil. J Am Soc Nephrol 1998; 9: 1407-1415.
19. PENNY MJ, BOYD RA, HALL BM. Mycophenolate mofetil prevents the induction of active Heymann nephritis: Association with Th2 cytokine inhibition. J Am Soc Nephrol 1998; 9: 2272-2282.
20. HUBSCH H, MONTANE B, ABITBOL C, et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: The Miami experience. Pediatr Nephrol 2005; 20: 210-216.
21. BAUM MA, Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 2004; 8: 329-333.
22. BAUM MA, HO M, STABLEIN D, et al. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr Transplant 2002; 6: 488-492.
23. ODORICO JS, KNECHTLE SJ, RAYHILL SC, et al. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996; 61: 228-234.
24. FUJISAWA M, IIJIMA K, ISHIMURA T, et al. Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation. Pediatr Nephrol 2002; 17: 165-168.